iRhythm Holdings, Inc. (IRTC)

From the record

iRhythm Holdings, Inc.'s filings since 2017 show 5 warning events of 4 kinds: a notice about its exchange listing (8-K item 3.01, the latest 2019-11-19); an auditor change (8-K item 4.01, the latest 2026-04-01); a material cybersecurity incident (8-K item 1.05, the latest 2026-06-15); a late-report notice (Form NT 10-K or NT 10-Q, 2 times, the latest 2019-11-13) (its current reports).

From the record

iRhythm Holdings, Inc.'s 10 filed years say what it did: revenue went from $64 million in fiscal 2016 to $747 million in fiscal 2025, up 31.4% a year; it rose in 9 of 9 years; it never fell from a peak; net income was positive in 0 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, iRhythm Holdings, Inc.'s diluted share count grew about 2.3% a year, and dividends and buybacks returned about 73% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 66 sales (20 under scheduled 10b5-1 plans) and 1 purchase of their own stock on the open market in the year to 2026-09-30, buying about $57 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, iRhythm Holdings, Inc. lost about 29 cents for every dollar of shareholders' money, and gross profitability: its products earned about 52 cents per dollar of everything the company owns. Leverage: it owed about 85 cents per dollar of assets, and net share issuance: its share count grew 2.6% over the year (the filed statements).

From the record

iRhythm Holdings, Inc.'s standing among 109 graded names in its industry family: revenue of $747 million in fiscal 2025 ranks in the top 23% by size; a net margin of -6% ranks in the top 35%; revenue growth of 22% a year over the last 3 filed years ranks in the top 34% (its annual reports).

From the record

iRhythm Holdings, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Blackford, Quentin S. (President and CEO, as filed), filing under that title since 2021-10-05, 5.1 years (top 49% of its family); the 19 officers and directors filing in the last fifteen months have been on the record a median of 4.3 years (bottom 30%); 9 officer or director changes were reported on Form 8-K since 2023-11-13, against the 19 people in charge now (top 44%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

iRhythm Holdings, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $236 million against no long-term debt tagged leaves 23.1% of its assets as net cash, top 35% of its family; cash from operations less capital spending is 4.6% of revenue (top 29%); a gross margin of 70.6% (top 31%); research spending of 11.3% of revenue (top 49%) (its annual report).

From the record

iRhythm Holdings, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 22% a year over the last three filed years against 31.4% over all 10, slowing (bottom 27% of its family); the newest year grew 26.3% (top 26%); research spending grew 22% a year (top 20%); capital spending grew 15.8% a year (top 28%) (its annual reports). iRhythm Holdings, Inc. reported 4 product lines in fiscal 2025: Commercial Payors at $392 million (53%), Centers for Medicare and Medicaid at $179 million (24%), Healthcare Institutions at $126 million (17%), and 1 more; 4 of 4 grew against the year before (its annual report).

From the record

iRhythm Holdings, Inc.'s newest year against its own record: revenue of $747 million in fiscal 2025 came in 5.2% above the $710 million its prior three years' pace pointed to (top 22% of its family); net income of $45 million against a prior three-year average of $118 million (top 29%); a net margin of -6% against -24.2% before (top 37%) (its annual reports).